INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.77 Million USD | 305.76% |
| 2022 | 1.66 Million USD | -12.18% |
| 2021 | 1.9 Million USD | 3143.1% |
| 2020 | 58.63 Thousand USD | -86.55% |
| 2019 | 436.1 Thousand USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 131.72 Thousand USD | 0.0% |
| 2016 | 131.72 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 96.46 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.17 Million USD | -3.35% |
| 2024 Q1 | 1.21 Million USD | -3.23% |
| 2023 FY | 6.77 Million USD | 305.76% |
| 2023 Q3 | 6.71 Million USD | 73.43% |
| 2023 Q4 | 6.77 Million USD | 0.88% |
| 2023 Q2 | 3.87 Million USD | 140.47% |
| 2023 Q1 | 1.61 Million USD | -3.55% |
| 2022 Q3 | 1.72 Million USD | -3.27% |
| 2022 Q4 | 1.66 Million USD | -3.41% |
| 2022 FY | 1.66 Million USD | -12.18% |
| 2022 Q1 | 1.84 Million USD | -2.99% |
| 2022 Q2 | 1.78 Million USD | -3.11% |
| 2021 Q1 | 52.78 Thousand USD | -9.97% |
| 2021 Q2 | 1.35 Million USD | 2467.43% |
| 2021 FY | 1.9 Million USD | 3143.1% |
| 2021 Q4 | 1.9 Million USD | 43.22% |
| 2021 Q3 | 1.32 Million USD | -2.04% |
| 2020 Q1 | 75.99 Thousand USD | -82.57% |
| 2020 FY | 58.63 Thousand USD | -86.55% |
| 2020 Q3 | 671.95 Thousand USD | -37.1% |
| 2020 Q2 | 1.06 Million USD | 1305.72% |
| 2020 Q4 | 58.63 Thousand USD | -91.27% |
| 2019 Q2 | 347.2 Thousand USD | 0.0% |
| 2019 Q3 | 390.77 Thousand USD | 12.55% |
| 2019 FY | 436.1 Thousand USD | 0.0% |
| 2019 Q4 | 436.1 Thousand USD | 11.6% |
| 2019 Q1 | - USD | 0.0% |
| 2018 Q1 | 131.72 Thousand USD | 0.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q2 | 188.16 Thousand USD | 42.85% |
| 2017 Q1 | 131.72 Thousand USD | 0.0% |
| 2017 Q3 | 131.72 Thousand USD | 0.0% |
| 2017 Q2 | 131.72 Thousand USD | 0.0% |
| 2017 Q4 | 131.72 Thousand USD | 0.0% |
| 2017 FY | 131.72 Thousand USD | 0.0% |
| 2016 FY | 131.72 Thousand USD | 0.0% |
| 2016 Q3 | 131.72 Thousand USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | 131.72 Thousand USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | 96.46 Thousand USD | 0.0% |
| 2009 Q3 | - USD | -100.0% |
| 2009 Q2 | 96.46 Thousand USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | 96.46 Thousand USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | 96.46 Thousand USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 81.231% |
| BrainsWay Ltd. | 239 Thousand USD | -2735.183% |
| Cerus Corporation | 59.79 Million USD | 88.668% |
| Envoy Medical, Inc. | 404 Thousand USD | -1577.249% |
| electroCore, Inc. | 537 Thousand USD | -1161.841% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -56367.392% |
| IceCure Medical Ltd | 376 Thousand USD | -1702.151% |
| Inogen, Inc. | 18.27 Million USD | 62.911% |
| OrthoPediatrics Corp. | 13.45 Million USD | 49.654% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -3305.069% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -1762.975% |
| MaxCyte, Inc. | 17.96 Million USD | 62.29% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -12156.868% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 92.722% |
| PAVmed Inc | 2.96 Million USD | -128.922% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -9.045% |
| RxSight, Inc. | 1.21 Million USD | -459.545% |
| Sight Sciences, Inc. | 31.7 Million USD | 78.63% |
| SI-BONE, Inc. | 36.06 Million USD | 81.211% |
| TELA Bio, Inc. | 40.51 Million USD | 83.275% |
| Treace Medical Concepts, Inc. | 53 Million USD | 87.217% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -345.502% |
| Acutus Medical, Inc. | 32.65 Million USD | 79.249% |
| Talis Biomedical Corporation | 16.78 Million USD | 59.633% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -67.518% |
| CVRx, Inc. | 30.38 Million USD | 77.697% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -566.328% |
| Bioventus Inc. | 366.99 Million USD | 98.154% |
| Venus Concept Inc. | 70.79 Million USD | 90.428% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -444.702% |
| LivaNova PLC | 568.54 Million USD | 98.808% |
| 908 Devices Inc. | 3.92 Million USD | -72.463% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 98.674% |
| Nemaura Medical Inc. | 3.08 Million USD | -119.458% |
| NeuroPace, Inc. | 56.95 Million USD | 88.103% |
| LENSAR, Inc. | 1.75 Million USD | -287.205% |
| Apyx Medical Corporation | 33.18 Million USD | 79.581% |
| Cutera, Inc. | 418.69 Million USD | 98.382% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 54.958% |
| BioSig Technologies, Inc. | 103 Thousand USD | -6478.725% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 74.814% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 31.892% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.544% |
| Axonics, Inc. | 25.84 Million USD | 73.777% |
| Outset Medical, Inc. | 134.59 Million USD | 94.966% |
| IRIDEX Corporation | 1.75 Million USD | -286.984% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 86.801% |
| IRadimed Corporation | 1.61 Million USD | -319.551% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -3750.049% |
| Telesis Bio, Inc. | 5.26 Million USD | -28.603% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -13.478% |
| Varex Imaging Corporation | 464.2 Million USD | 98.54% |
| Quipt Home Medical Corp. | 60.82 Million USD | 88.859% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -1052.396% |
| Pulmonx Corporation | 35.08 Million USD | 80.689% |
| Dynatronics Corporation | 3.25 Million USD | -107.953% |
| Modular Medical, Inc. | 817 Thousand USD | -729.386% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -4387.475% |
| Semler Scientific, Inc. | 70 Thousand USD | -9580.124% |
| InMode Ltd. | 6.61 Million USD | -2.466% |
| Bruker Corporation | 1.14 Billion USD | 99.408% |
| Cytosorbents Corporation | 2.54 Million USD | -166.475% |
| DexCom, Inc. | 2.57 Billion USD | 99.737% |
| Align Technology, Inc. | 96.96 Million USD | 93.012% |
| Viveve Medical, Inc. | 5.12 Million USD | -32.242% |
| ZimVie Inc. | 508.79 Million USD | 98.668% |
| Movano Inc. | 15.00 USD | -45173813.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 62.615% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 98.3% |
| Profound Medical Corp. | 4.97 Million USD | -36.219% |
| Insulet Corporation | 1.36 Billion USD | 99.504% |
| enVVeno Medical Corporation | 1.06 Million USD | -536.85% |
| Surmodics, Inc. | 29.4 Million USD | 76.956% |
| iCAD, Inc. | 273 Thousand USD | -2382.083% |
| Nuwellis, Inc. | 221 Thousand USD | -2966.103% |
| Biotricity, Inc. | 10.85 Million USD | 37.581% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 80.612% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -942.874% |
| InspireMD, Inc. | 1.03 Million USD | -552.802% |
| PAVmed Inc. | 2.96 Million USD | -128.922% |
| BIOLASE, Inc. | 13.98 Million USD | 51.547% |
| Beyond Air, Inc. | 14.72 Million USD | 53.97% |
| FONAR Corporation | 37.92 Million USD | 82.135% |
| AxoGen, Inc. | 46.6 Million USD | 85.46% |
| Vivani Medical, Inc. | 19.31 Million USD | 64.914% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 84.811% |
| Inari Medical, Inc. | 30.35 Million USD | 77.677% |
| UFP Technologies, Inc. | 28 Million USD | 75.8% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -1461.148% |
| Tenon Medical, Inc. | 428 Thousand USD | -1483.198% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -576.256% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -214.848% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.676% |
| Sintx Technologies, Inc. | 3.68 Million USD | -83.783% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 81.796% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -1052.396% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -1036.927% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.241% |
| TransMedics Group, Inc. | 506.2 Million USD | 98.661% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -1016.324% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -7226.688% |
| Hyperfine, Inc. | 64 Thousand USD | -10487.636% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 96.41% |
| Biomerica, Inc. | 459 Thousand USD | -1376.272% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1407.529% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -3466.606% |
| Silk Road Medical, Inc | 75.62 Million USD | 91.04% |